Yulin Chang

727 total citations
27 papers, 535 citations indexed

About

Yulin Chang is a scholar working on Molecular Biology, Hematology and Surgery. According to data from OpenAlex, Yulin Chang has authored 27 papers receiving a total of 535 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Hematology and 5 papers in Surgery. Recurrent topics in Yulin Chang's work include Multiple Myeloma Research and Treatments (6 papers), Protein Degradation and Inhibitors (6 papers) and Anesthesia and Pain Management (5 papers). Yulin Chang is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Protein Degradation and Inhibitors (6 papers) and Anesthesia and Pain Management (5 papers). Yulin Chang collaborates with scholars based in China, United States and Taiwan. Yulin Chang's co-authors include Zhaohui Liu, Lili Yu, Min Qu, Qiang Yang, Panpan Song, Liang‐Yi Hung, Tang K. Tang, Zhengping Wang, Xiaojing Huang and Yuan-Chang Xiong and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Orthopaedics and Related Research.

In The Last Decade

Yulin Chang

26 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yulin Chang China 16 276 87 67 67 57 27 535
Steven D. Funk United States 13 282 1.0× 104 1.2× 77 1.1× 105 1.6× 52 0.9× 16 638
Michael Tranter United States 15 347 1.3× 39 0.4× 79 1.2× 40 0.6× 27 0.5× 34 740
Masayuki Noritake Japan 16 243 0.9× 45 0.5× 127 1.9× 24 0.4× 42 0.7× 30 730
Liang Xie United States 13 248 0.9× 99 1.1× 46 0.7× 37 0.6× 15 0.3× 20 568
Chi Liu China 15 411 1.5× 163 1.9× 77 1.1× 43 0.6× 20 0.4× 39 834
Qiongxiu Zhou China 10 219 0.8× 65 0.7× 14 0.2× 44 0.7× 61 1.1× 26 423
Jung Yeon Ghee South Korea 14 160 0.6× 109 1.3× 102 1.5× 40 0.6× 20 0.4× 32 696
Yanjuan Zhu China 15 225 0.8× 73 0.8× 76 1.1× 43 0.6× 20 0.4× 23 655
Amar Kapoor United Kingdom 12 211 0.8× 120 1.4× 57 0.9× 13 0.2× 71 1.2× 14 480
Hirofumi Shigeta Japan 14 183 0.7× 81 0.9× 121 1.8× 49 0.7× 16 0.3× 24 692

Countries citing papers authored by Yulin Chang

Since Specialization
Citations

This map shows the geographic impact of Yulin Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yulin Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yulin Chang more than expected).

Fields of papers citing papers by Yulin Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yulin Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yulin Chang. The network helps show where Yulin Chang may publish in the future.

Co-authorship network of co-authors of Yulin Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Yulin Chang. A scholar is included among the top collaborators of Yulin Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yulin Chang. Yulin Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Jae Mann, et al.. (2024). 802MO Real-world comparison of overall survival between BCMA - bispecific and CAR-T therapies in multiple myeloma. Annals of Oncology. 35. S597–S597. 1 indexed citations
2.
3.
Yu, Lili, Xiuling Cui, Panpan Song, et al.. (2022). Perioperative pectoral nerve block type II and postoperative recurrence in breast cancer: a randomized controlled trial. BMC Surgery. 22(1). 447–447. 5 indexed citations
4.
5.
Cortes, Jörge E., Donna E. Hogge, Scott R. Solomon, et al.. (2021). Five-Year Final Results of a Phase 3 Study of CPX-351 Versus 7+3 in Older Adults with Newly Diagnosed High-Risk/Secondary Acute Myeloid Leukemia (AML): Outcomes By Age Subgroup and Among Responders. Transplantation and Cellular Therapy. 27(3). S126–S127. 3 indexed citations
6.
Wang, Xupeng, Yang Bai, Yan Li, et al.. (2021). Carbon Monoxide–Releasing Molecule-3 Alleviates Kupffer Cell Pyroptosis Induced by Hemorrhagic Shock and Resuscitation via sGC-cGMP Signal Pathway. Inflammation. 44(4). 1330–1344. 8 indexed citations
7.
Liu, Zhaohui, Yan Li, Chunlei Li, et al.. (2021). Delivery of coenzyme Q10 with mitochondria-targeted nanocarrier attenuates renal ischemia-reperfusion injury in mice. Materials Science and Engineering C. 131. 112536–112536. 18 indexed citations
8.
Lancet, Jeffrey E., Geoffrey L. Uy, Laura F. Newell, et al.. (2020). Five-year final results of a phase III study of CPX-351 versus 7+3 in older adults with newly diagnosed high-risk/secondary AML.. Journal of Clinical Oncology. 38(15_suppl). 7510–7510. 16 indexed citations
9.
Liu, Zhaohui, Ji Zhang, Fang Zhang, & Yulin Chang. (2020). Propofol post-conditioning lessens renal ischemia/reperfusion-induced acute lung injury associated with autophagy and apoptosis through MAPK signals in rats. Gene. 741. 144562–144562. 15 indexed citations
10.
Liu, Zhaohui, et al.. (2020). Neutrophil membrane-enveloped nanoparticles for the amelioration of renal ischemia-reperfusion injury in mice. Acta Biomaterialia. 104. 158–166. 49 indexed citations
11.
Hari, Parameswaran, Claudia E. Paba‐Prada, Peter M. Voorhees, et al.. (2019). Efficacy and safety results from a phase 1b/2, multicenter, open-label study of oprozomib and dexamethasone in patients with relapsed and/or refractory multiple myeloma. Leukemia Research. 83. 106172–106172. 15 indexed citations
12.
13.
14.
Shah, Jatin J., Saad Z. Usmani, Edward A. Stadtmauer, et al.. (2019). Oprozomib, pomalidomide, and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 19(9). 570–578.e1. 22 indexed citations
15.
Liu, Zhaohui, Min Qu, Qiang Yang, & Yulin Chang. (2018). Lipoxin A4 ameliorates renal ischaemia–reperfusion‐induced acute lung injury in rats. Clinical and Experimental Pharmacology and Physiology. 46(1). 65–74. 10 indexed citations
16.
Liu, Zhaohui, Min Qu, Lili Yu, Panpan Song, & Yulin Chang. (2018). Artesunate Inhibits Renal Ischemia-Reperfusion-Mediated Remote Lung Inflammation Through Attenuating ROS-Induced Activation of NLRP3 Inflammasome. Inflammation. 41(4). 1546–1556. 53 indexed citations
17.
18.
Chang, Yulin, Xiaojing Huang, Zhaohui Liu, et al.. (2012). Dexmedetomidine inhibits the secretion of high mobility group box 1 from lipopolysaccharide-activated macrophages In vitro. Journal of Surgical Research. 181(2). 308–314. 47 indexed citations
19.
Hung, Liang‐Yi, et al.. (2008). Functional characterization of the microtubule-binding and -destabilizing domains of CPAP and d-SAS-4. Experimental Cell Research. 314(14). 2591–2602. 58 indexed citations
20.
deAndrade, J. Robin, H. David Reines, David Howe, et al.. (1996). Ketorolac Versus Meperidine for Pain Relief After Orthopaedic Surgery. Clinical Orthopaedics and Related Research. 325(325). 302–312. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steven D. Funk Breakdown of academic impact, for papers by Michael Tranter Breakdown of academic impact, for papers by Masayuki Noritake Breakdown of academic impact, for papers by Liang Xie Breakdown of academic impact, for papers by Chi Liu Breakdown of academic impact, for papers by Qiongxiu Zhou Breakdown of academic impact, for papers by Jung Yeon Ghee Breakdown of academic impact, for papers by Yanjuan Zhu Breakdown of academic impact, for papers by Amar Kapoor Breakdown of academic impact, for papers by Hirofumi Shigeta
Rankless by CCL
2026